Stock Events

Stock Events

Prime Medicine 

$3.41
0
+$0.18+5.57% Today

Statistics

Day High
3.48
Day Low
3.41
52W High
-
52W Low
-
Volume
6,805
Avg. Volume
-
Mkt Cap
615.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 19
$0.8
Jun 19
$0.2
Dec 18
$0.21
Sep 18
$0.23
Jun 18
$0.15
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

7MayExpected
Q3 2025
Q4 2025
Next
-0.32
-0.29
-0.25
-0.22
Expected EPS
-0.2506
Actual EPS
N/A

Financials

-6,566.61%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
5.97MRevenue
-391.76MNet Income

Analyst Ratings

$7.56Average Price Target
The highest estimate is 11.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PRME.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics is a leader in the development of gene-based medicine, directly competing with Prime Medicine's gene editing technology.
Editas Medicine
EDIT
Mkt Cap276.95M
Editas Medicine focuses on developing CRISPR gene editing treatments, making it a direct competitor in the gene therapy space.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is known for its advancements in CRISPR/Cas9 technology for gene editing, competing in the same field as Prime Medicine.
Beam Therapeutics
BEAM
Mkt Cap2.53B
Beam Therapeutics uses base editing, a form of gene editing that competes with Prime Medicine's technology for precision and reduced off-target effects.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics works on genome editing and gene therapy, including zinc finger nuclease technology, offering alternatives to Prime Medicine's approaches.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers long-read sequencing technologies that are crucial for gene editing research, indirectly competing by enabling gene editing advancements.
Twist Bioscience
TWST
Mkt Cap1.99B
Twist Bioscience operates in the synthetic biology space, providing tools and technologies that support gene editing, thus indirectly competing with Prime Medicine.

About

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
ISIN
US74168J1016

Listings

XNAS
US
PRME
BOATS
BOATS
PRME.BOATS

0 Comments

Share your thoughts

FAQ

What is Prime Medicine stock price today?▼
The current price of PRME.BOATS is $3.41 USD — it has increased by +5.57% in the past 24 hours. Watch Prime Medicine stock price performance more closely on the chart.
What is Prime Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Prime Medicine stocks are traded under the ticker PRME.BOATS.
What is Prime Medicine market cap?▼
Today Prime Medicine has the market capitalization of 615.54M
When is the next Prime Medicine earnings date?▼
Prime Medicine is going to release the next earnings report on May 07, 2026.
What were Prime Medicine earnings last quarter?▼
PRME.BOATS earnings for the last quarter are -0.22 USD per share, whereas the estimation was -0.25 USD resulting in a +12.48% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Prime Medicine revenue for the last year?▼
Prime Medicine revenue for the last year amounts to 5.97M USD.
What is Prime Medicine net income for the last year?▼
PRME.BOATS net income for the last year is -391.76M USD.
Does Prime Medicine pay dividends?▼
Yes, PRME.BOATS dividends are paid quarterly. The last dividend per share was 0.8 USD. As of today, Dividend Yield (FWD)% is 0%.
When did Prime Medicine complete a stock split?▼
Prime Medicine has not had any recent stock splits.